287 related articles for article (PubMed ID: 31173076)
1. A human embryonic stem cell reporter line for monitoring chemical-induced cardiotoxicity.
Tsai SY; Ghazizadeh Z; Wang HJ; Amin S; Ortega FA; Badieyan ZS; Hsu ZT; Gordillo M; Kumar R; Christini DJ; Evans T; Chen S
Cardiovasc Res; 2020 Mar; 116(3):658-670. PubMed ID: 31173076
[TBL] [Abstract][Full Text] [Related]
2. Myosin light chain 2 marks differentiating ventricular cardiomyocytes derived from human embryonic stem cells.
Luo XL; Zhang P; Liu X; Huang S; Rao SL; Ding Q; Yang HT
Pflugers Arch; 2021 Jul; 473(7):991-1007. PubMed ID: 34031754
[TBL] [Abstract][Full Text] [Related]
3. Myocardial commitment from human pluripotent stem cells: Rapid production of human heart grafts.
Garreta E; de Oñate L; Fernández-Santos ME; Oria R; Tarantino C; Climent AM; Marco A; Samitier M; Martínez E; Valls-Margarit M; Matesanz R; Taylor DA; Fernández-Avilés F; Izpisua Belmonte JC; Montserrat N
Biomaterials; 2016 Aug; 98():64-78. PubMed ID: 27179434
[TBL] [Abstract][Full Text] [Related]
4. Functional expression and pharmaceutical efficacy of cardiac-specific ion channels in human embryonic stem cell-derived cardiomyocytes.
Kim HS; Yoon JW; Li H; Jeong GO; Park JJ; Shin SE; Jang IH; Kim JH; Park WS
Sci Rep; 2017 Oct; 7(1):13821. PubMed ID: 29062050
[TBL] [Abstract][Full Text] [Related]
5. Advanced Single-Cell Mapping Reveals that in hESC Cardiomyocytes Contraction Kinetics and Action Potential Are Independent of Myosin Isoform.
Weber N; Kowalski K; Holler T; Radocaj A; Fischer M; Thiemann S; de la Roche J; Schwanke K; Piep B; Peschel N; Krumm U; Lingk A; Wendland M; Greten S; Schmitto JD; Ismail I; Warnecke G; Zywietz U; Chichkov B; Meißner J; Haverich A; Martin U; Brenner B; Zweigerdt R; Kraft T
Stem Cell Reports; 2020 May; 14(5):788-802. PubMed ID: 32302556
[TBL] [Abstract][Full Text] [Related]
6. A COUP-TFII Human Embryonic Stem Cell Reporter Line to Identify and Select Atrial Cardiomyocytes.
Schwach V; Verkerk AO; Mol M; Monshouwer-Kloots JJ; Devalla HD; Orlova VV; Anastassiadis K; Mummery CL; Davis RP; Passier R
Stem Cell Reports; 2017 Dec; 9(6):1765-1779. PubMed ID: 29173897
[TBL] [Abstract][Full Text] [Related]
7. Fluorescent hiPSC-derived MYH6-mScarlet cardiomyocytes for real-time tracking, imaging, and cardiotoxicity assays.
Maria Cherian R; Prajapati C; Penttinen K; Häkli M; Koivisto JT; Pekkanen-Mattila M; Aalto-Setälä K
Cell Biol Toxicol; 2023 Feb; 39(1):145-163. PubMed ID: 35870039
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid promotes metabolic maturation of human Embryonic Stem Cell-derived Cardiomyocytes.
Miao S; Zhao D; Wang X; Ni X; Fang X; Yu M; Ye L; Yang J; Wu H; Han X; Qu L; Li L; Lan F; Shen Z; Lei W; Zhao ZA; Hu S
Theranostics; 2020; 10(21):9686-9701. PubMed ID: 32863954
[TBL] [Abstract][Full Text] [Related]
9. Maturation of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in 3D collagen matrix: Effects of niche cell supplementation and mechanical stimulation.
Zhang W; Kong CW; Tong MH; Chooi WH; Huang N; Li RA; Chan BP
Acta Biomater; 2017 Feb; 49():204-217. PubMed ID: 27890729
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of the electrophysiological phenotype of human embryonic stem cell-derived ventricular cardiomyocytes: insights for driven maturation and hypertrophic growth.
Chow MZ; Geng L; Kong CW; Keung W; Fung JC; Boheler KR; Li RA
Stem Cells Dev; 2013 Oct; 22(19):2678-90. PubMed ID: 23656529
[TBL] [Abstract][Full Text] [Related]
11. Small-molecule inhibitors of the Wnt pathway potently promote cardiomyocytes from human embryonic stem cell-derived mesoderm.
Willems E; Spiering S; Davidovics H; Lanier M; Xia Z; Dawson M; Cashman J; Mercola M
Circ Res; 2011 Aug; 109(4):360-4. PubMed ID: 21737789
[TBL] [Abstract][Full Text] [Related]
12. Cardiotoxicity evaluation using human embryonic stem cells and induced pluripotent stem cell-derived cardiomyocytes.
Zhao Q; Wang X; Wang S; Song Z; Wang J; Ma J
Stem Cell Res Ther; 2017 Mar; 8(1):54. PubMed ID: 28279214
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells.
Holmgren G; Synnergren J; Bogestål Y; Améen C; Åkesson K; Holmgren S; Lindahl A; Sartipy P
Toxicology; 2015 Feb; 328():102-11. PubMed ID: 25529476
[TBL] [Abstract][Full Text] [Related]
14. Apela Promotes Cardiomyocyte Differentiation from Transgenic Human Embryonic Stem Cell Lines.
Wang Z; Huang J
Appl Biochem Biotechnol; 2019 Oct; 189(2):396-410. PubMed ID: 31025171
[TBL] [Abstract][Full Text] [Related]
15. Functional and Transcriptional Characterization of Histone Deacetylase Inhibitor-Mediated Cardiac Adverse Effects in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Kopljar I; Gallacher DJ; De Bondt A; Cougnaud L; Vlaminckx E; Van den Wyngaert I; Lu HR
Stem Cells Transl Med; 2016 May; 5(5):602-12. PubMed ID: 27034410
[TBL] [Abstract][Full Text] [Related]
16. Tomatidine-stimulated maturation of human embryonic stem cell-derived cardiomyocytes for modeling mitochondrial dysfunction.
Kim YS; Yoon JW; Kim D; Choi S; Kim HK; Youm JB; Han J; Heo SC; Hyun SA; Seo JW; Kim DH; Kim JH
Exp Mol Med; 2022 Apr; 54(4):493-502. PubMed ID: 35379934
[TBL] [Abstract][Full Text] [Related]
17. Modeling Hypoxic Stress In Vitro Using Human Embryonic Stem Cells Derived Cardiomyocytes Matured by FGF4 and Ascorbic Acid Treatment.
Choi SC; Seo HR; Cui LH; Song MH; Noh JM; Kim KS; Choi JH; Kim JH; Park CY; Joo HJ; Hong SJ; Ko TH; Choi JI; Kim HJ; Kim JH; Paek SH; Park JN; Kim DH; Jang Y; Park Y; Lim DS
Cells; 2021 Oct; 10(10):. PubMed ID: 34685725
[TBL] [Abstract][Full Text] [Related]
18. Disruption of cardiogenesis in human embryonic stem cells exposed to trichloroethylene.
Jiang Y; Wang D; Zhang G; Wang G; Tong J; Chen T
Environ Toxicol; 2016 Nov; 31(11):1372-1380. PubMed ID: 25847060
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Cultured Human Cardiomyocyte Clusters Obtained from Embryos/Fetuses or Derived from Human Embryonic Stem Cells.
Grubb S; Vestergaard ML; Andersen AS; Rasmussen KK; Mamsen LS; Tuckute G; Grunnet-Lauridsen K; Møllgård K; Ernst E; Christensen ST; Calloe K; Andersen CY
Stem Cells Dev; 2019 May; 28(9):608-619. PubMed ID: 30755084
[TBL] [Abstract][Full Text] [Related]
20. MLP-deficient human pluripotent stem cell derived cardiomyocytes develop hypertrophic cardiomyopathy and heart failure phenotypes due to abnormal calcium handling.
Li X; Lu WJ; Li Y; Wu F; Bai R; Ma S; Dong T; Zhang H; Lee AS; Wang Y; Lan F
Cell Death Dis; 2019 Aug; 10(8):610. PubMed ID: 31406109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
